Annual vaccination in the US against influenza A and B viruses is recommended for everyone ≥6 months old without a contraindication.1,2 Influenza vaccines available in the US for the 2024-2025 season are listed in Table 2.
COMPOSITION — All influenza vaccines available in the US this season are trivalent: they contain two influenza A virus antigens and one influenza B virus antigen (see Table 1).3 Influenza A viruses are the primary cause...
RELEASE
The potassium-competitive acid blocker vonoprazan (Voquezna – Phathom), which was approved earlier for treatment of erosive esophagitis, has now been approved by the FDA for relief of heartburn associated with nonerosive gastroesophageal reflux disease (GERD) in adults.1 Vonoprazan is also available copackaged with amoxicillin (Voquezna Dual Pak) and with amoxicillin and clarithromycin (Voquezna Triple Pak) for treatment of Helicobacter pylori infection.2
GERD ― Heartburn and regurgitation are the classic symptoms of GERD. Other symptoms may include chest pain and chronic cough. Drugs that suppress gastric acid are the standard treatment for GERD. Proton pump inhibitors (PPIs) are more effective than H2-receptor antagonists (H2RAs) in relieving heartburn. Most patients will have a relapse of …